Corona Remedies Limited IPO
Pharmaceuticals · DRHP 30 Apr 2025 · listed 15 Dec 2025
Follow this IPOuse-of-proceeds reports, on Telegram
- Issue price
- ₹1,062.00
- band ₹1,008.00 to ₹1,062.00
- Issue size
- ₹655.4 cr
- fresh - · OFS ₹655 cr
- Lot
- 14 shares
- ₹14,868 at the top of the band
- Subscription window
- 8 Dec to 10 Dec
- 2025
- Listing
- 15 Dec 2025
- NSE
- Subscribed
- 73.0x
- retail 18.8x
About the Corona Remedies IPO
Corona Remedies Limited raised ₹655 crore through a mainboard IPO on NSE and BSE: an offer for sale of ₹655 crore.
Bidding ran Mon 8 Dec to Wed 10 Dec, at an issue price of ₹1,062 a share, in lots of 14 shares. The shares listed on 15 Dec 2025.
The book-running lead managers are JM Financial Limited, IIFL Capital Services Limited and Kotak Mahindra Capital Company Limited. The registrar, which handles allotment, is Bigshare Services Private Limited.
The issue was subscribed 73.05 times overall, with the retail portion at 18.76 times, as the exchange's bid book showed.
The draft offer document was filed on 30 Apr 2025.
newboard writes its studies from the offer document before an issue lists, and this one listed without one. The figures on this page are the exchange's and the offer document's, each with its source.
Corona Remedies IPO: questions answered
When was the Corona Remedies IPO open, and what were the price band and lot size?
Bidding ran Mon 8 Dec to Wed 10 Dec. The issue price is ₹1,062 a share. One lot is 14 shares, ₹14,868 at the upper end of the band.
When did the Corona Remedies IPO list?
The shares listed on 15 Dec 2025 on NSE and BSE.
How do I check the Corona Remedies IPO allotment status?
Allotment is finalised by the registrar, Bigshare Services Private Limited, usually the working day after the issue closes. Check it on the registrar's website or on BSE and NSE with a PAN, application number or DP ID. Shares not allotted have their blocked amount released by the refund date.
The Corona Remedies IPO allotment status page, with the direct links
Who are the registrar and lead managers of the Corona Remedies IPO?
The book-running lead managers are JM Financial Limited, IIFL Capital Services Limited and Kotak Mahindra Capital Company Limited. The registrar, which handles applications and allotment, is Bigshare Services Private Limited.
How many times was the Corona Remedies IPO subscribed?
73.05 times overall, as the exchange's bid book last showed: qualified institutions 114.49 times, non-institutional investors 109.9 times and retail 18.76 times.
Is the Corona Remedies IPO a fresh issue or an offer for sale?
It includes an offer for sale of ₹655 crore: that money goes to the shareholders selling, not to the company.
What is the Corona Remedies IPO GMP?
newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.
Corona Remedies IPO: the next step, on Telegram
A message when there is news on each use-of-proceeds report the company files. Free, no account, leave in one tap. Send /stop to end it.
Not on this page yet: an offer-document study, the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.